79111421 - EXELTIS

Information

  • Trademark
  • 79111421
  • Serial Number
    79111421
  • Registration Number
    4594815
  • Filing Date
    March 05, 2012
    12 years ago
  • Registration Date
    September 02, 2014
    10 years ago
  • Transaction Date
    August 07, 2024
    5 months ago
  • Status Date
    August 07, 2024
    5 months ago
  • Published for Opposition Date
    November 12, 2013
    11 years ago
  • Location Date
    August 07, 2024
    5 months ago
  • Status Code
    706
  • Current Location
    Historical data usage
    Employee Name
    STRUCK, ROBERT J
  • Attorney Name
    Vivian Ortiz-Ponce
  • Owners
Mark Drawing Code
4
Mark Identification
EXELTIS
Case File Statements
  • B00001: In the Statement, Page 1, line 5," Pharmaceutical preparation for use in treating" should be deleted, and, "Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders, dermatological diseases and disorders," should be inserted, and, In the Statement, Page 1, line 8, "genitourinary diseases," should be deleted, and, " genitourinary disorders," should be inserted, and In the Statement, Page 1, lines 10 and 11, ", neurological diseases, psychiatric diseases, central nervous system" should be deleted, and, "; pharmaceutical preparations for the treatment of diseases of the" should be inserted, and, In the Statement, Page 1, line 11, before, RESPIRATORY, "diseases of the" should be inserted, and, In the Statement, Page 1, line 12, "circulatory system should be deleted, and, "circulatory diseases" should be inserted, and, "oral" should be deleted, and, "mouth" should be inserted, and, In the Statement, Page 1, line 13, "headaches, migraine," and "hepatic treatments," should be deleted, and, In the Statement, Page 1, line 14, "blood pressure and rheumatic treatments;" should be deleted, and, "treatment of the liver;" should be inserted, and, In the Statement, Page 1, line 27, after FORM, "; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted, and, In the Statement, Page 1, lines 28 and 29, "; medical instruments for use in gynecological and respiratory disorders;" should be deleted, and, "medical instruments for gynecological disorders, ophthalmic disorders, dermatological disorders, metabolic and respiratory disorders;" should be inserted, and, In the Statement, Page 2, line 5, after PRODUCTS, ", but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted, and, In the Statement, Page 2, lines 6 and 7, after, ENGINEERING, "all the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease" should be inserted.
  • GS0051: [ Pharmaceutical preparation for use in treating * ] Pharmaceutical preparations for the treatment of [ ophthalmic diseases and disorders, dermatological diseases and disorders, * digestive diseases and disorder, ] gynecological diseases and disorders, hormonal diseases and disorders [, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, * genitourinary disorders, * immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, psychiatric diseases, central nervous system, * ; pharmaceutical preparations for the treatment of diseases of the * musculoskeletal system, * diseases of the * respiratory system, circulatory system, * circulatory diseases, * viral diseases, glaucoma, dental and oral * mouth * diseases, headaches, migraine, obesity, hepatic treatments, * treatment of the liver; * cholesterol, blood pressure and rheumatic treatments; veterinary preparation for treating digestive diseases and disorder, gynecological diseases and disorders, blood disorders, cancer, cardiovascular diseases, vascular diseases, gastrointestinal diseases, genitourinary diseases, immunologic diseases, infectious diseases, inflammatory diseases, metabolic diseases and disorders, neurological diseases, central nervous system, musculoskeletal system, respiratory system, circulatory system, viral diseases, glaucoma, dental and oral diseases, headaches, migraine, obesity, hepatic treatments, cholesterol, blood pressure and rheumatic treatments; and dietetic foods adapted for medical use, namely, breads, pastas, crackers, chips, snack foods, packaged meals, nutritional food bars, sweets, dips, sauces and food supplements in pill, powder, capsule, beverage form, effervescent tablet and liquid form * ; none of the aforesaid products are preparations in connection with neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]
  • B00002: In the Statement, Page 1, line 40, "all" should be deleted, and, NONE, should be inserted.
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0351: [ Sales promotion for third parties, business management assistance; consulting on business management and marketing studies; presentation of goods on communication media, for retail purposes; business administration of product licenses and services for others; ] organization of exhibitions, trade fairs or congresses for business or advertising purposes, all relating to pharmaceutical, veterinary and biotechnological companies and for pharmaceutical, veterinary and biotechnological products *, but none of the aforesaid goods relating to neuroscience, including dementia, Alzheimer's disease and Parkinson's disease or to goods in the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease *
  • GS0101: [ Surgical apparatus and instruments; [ medical instruments for use in gynecological and respiratory disorders; ] *medical instruments for gynecological disorders, ophthalmic disorders, dermatological disorders, metabolic and respiratory disorders; * orthopedic devices for diagnostic and therapeutic use; suture materials ]
  • GS0421: [ Chemical, biological and pharmaceutical research services; engineering * all * none * the aforesaid goods relating to the field of neuroscience, including dementia, Alzheimer's disease and Parkinson's disease * ]
Case File Event Statements
  • 12/19/2012 - 12 years ago
    10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/26/2012 - 12 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 4/27/2012 - 12 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/1/2012 - 12 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 6/14/2012 - 12 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/19/2012 - 12 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/20/2012 - 12 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/20/2012 - 12 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/20/2012 - 12 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 7/7/2012 - 12 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 12/19/2012 - 12 years ago
    11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/18/2013 - 11 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/19/2012 - 12 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/20/2012 - 12 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/20/2012 - 12 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/21/2012 - 12 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/18/2013 - 12 years ago
    16 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/18/2013 - 12 years ago
    17 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/18/2013 - 12 years ago
    18 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/18/2013 - 11 years ago
    19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/18/2013 - 11 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/22/2013 - 11 years ago
    30 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 7/22/2013 - 11 years ago
    22 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 7/23/2013 - 11 years ago
    23 - ASSIGNED TO LIE Type: ALIE
  • 7/24/2013 - 11 years ago
    24 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/24/2013 - 11 years ago
    25 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/9/2013 - 11 years ago
    26 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 8/22/2013 - 11 years ago
    27 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/22/2013 - 11 years ago
    28 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/22/2013 - 11 years ago
    29 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 10/8/2013 - 11 years ago
    38 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 10/23/2013 - 11 years ago
    40 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 8/23/2013 - 11 years ago
    31 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/3/2013 - 11 years ago
    32 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 9/13/2013 - 11 years ago
    33 - WITHDRAWN FROM PUB OTQR REQUEST Type: PBTQ
  • 10/2/2013 - 11 years ago
    35 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 10/2/2013 - 11 years ago
    34 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 10/2/2013 - 11 years ago
    36 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 10/4/2013 - 11 years ago
    37 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/23/2013 - 11 years ago
    39 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/24/2014 - 10 years ago
    46 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 5/19/2014 - 10 years ago
    50 - IRREGULARITY ON REFUSAL FROM IB Type: IRRF
  • 10/23/2013 - 11 years ago
    41 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 11/12/2013 - 11 years ago
    42 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/12/2013 - 11 years ago
    43 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/13/2013 - 11 years ago
    44 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 12/3/2013 - 11 years ago
    45 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 3/10/2014 - 10 years ago
    47 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 5/6/2014 - 10 years ago
    48 - OPPOSITION NOTICE (IB REFUSAL) CREATED Type: OPNC
  • 5/8/2014 - 10 years ago
    49 - OPPOSITION NOTICE (IB REFUSAL) SENT TO IB Type: OPNS
  • 12/18/2015 - 9 years ago
    60 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 6/20/2014 - 10 years ago
    51 - REFUSAL PROCESSED BY IB Type: RFNP
  • 7/29/2014 - 10 years ago
    53 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 7/29/2014 - 10 years ago
    52 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 7/29/2014 - 10 years ago
    54 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 9/2/2014 - 10 years ago
    55 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/2/2014 - 10 years ago
    56 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/3/2014 - 10 years ago
    57 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/3/2014 - 10 years ago
    58 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/19/2014 - 10 years ago
    59 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 10/26/2017 - 7 years ago
    70 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN
  • 7/1/2016 - 8 years ago
    61 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 7/1/2016 - 8 years ago
    62 - LIMITATION FROM THE IB EXAMINED AND ENTERED Type: LIME
  • 3/11/2017 - 7 years ago
    63 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 3/30/2017 - 7 years ago
    64 - INVALIDATION PROCESSED Type: INPC
  • 3/30/2017 - 7 years ago
    65 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INPS
  • 9/21/2017 - 7 years ago
    66 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 9/22/2017 - 7 years ago
    67 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 10/6/2017 - 7 years ago
    68 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 10/23/2017 - 7 years ago
    69 - CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED Type: CORR
  • 10/26/2017 - 7 years ago
    71 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 2/28/2018 - 6 years ago
    72 - LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: LIMN
  • 9/14/2018 - 6 years ago
    73 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP
  • 9/2/2019 - 5 years ago
    74 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 9/2/2020 - 4 years ago
    75 - TEAS SECTION 71 RECEIVED Type: ES71
  • 12/8/2020 - 4 years ago
    76 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 12/9/2020 - 4 years ago
    78 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71
  • 12/9/2020 - 4 years ago
    77 - REGISTERED - PARTIAL SEC 71 ACCEPTED Type: 71.P
  • 8/9/2021 - 3 years ago
    79 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 8/20/2021 - 3 years ago
    80 - INVALIDATION PROCESSED Type: INPC
  • 3/24/2022 - 2 years ago
    83 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL
  • 8/7/2024 - 5 months ago
    85 - TEAS SECTION 71 RECEIVED Type: ES71
  • 8/7/2024 - 5 months ago
    86 - REGISTERED-SEC.71 ACCEPTED Type: 71AG
  • 8/7/2024 - 5 months ago
    87 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71
  • 9/2/2023 - a year ago
    84 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4
  • 8/20/2021 - 3 years ago
    81 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INPS
  • 9/19/2021 - 3 years ago
    82 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP